Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference
Aims Recent trial data demonstrate beneficial effects of active rhythm management in patients with atrial fibrillation (AF) and support the concept that a low arrhythmia burden is associated with a low risk of AF-related complications. The aim of this document is to summarize the key outcomes of the...
| Autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2024 |
| País: | España |
| Institución: | Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau) |
| Repositorio: | r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau |
| OAI Identifier: | oai:iibsantpau.fundanetsuite.com:p17682 |
| Acceso en línea: | https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=17682 http://ddd.uab.cat/record/305883 |
| Access Level: | acceso abierto |
| Palabra clave: | Atrial fibrillation Artificial intelligence Biomarkers Heart failure Atrial cardiomyopathy Cognitive function Dementia Outcomes Quality of care Cost Research Rhythm management Catheter ablation Anticoagulation Bleeding Research priorities Technology Stroke Integrated care Screening AFNET EHRA Guidelines Consensus statement |
| id |
ES_8f2d4b3f9c2ce71b01d25118b2ad2cb7 |
|---|---|
| oai_identifier_str |
oai:iibsantpau.fundanetsuite.com:p17682 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conferenceLinz, DAndrade, JGArbelo, EBoriani, GBreithardt, GCamm, AJCaso, VNielsen, JCDe Melis, MDe Potter, TDichtl, WDiederichsen, SZDobrev, DDoll, NDuncker, DDworatzek, EEckardt, LEisert, CFabritz, LFarkowski, MFilgueiras-Rama, DGoette, AGuasch, EHack, GHatem, SHaeusler, KGHealey, JSHeidbuechel, HHijazi, ZHofmeister, LHHove-Madsen, LHuebner, TKääb, SKotecha, DMalaczynska-Rajpold, KMerino, JLMetzner, AMont, LNg, GAOeff, MParwani, ASPuererfellner, HRavens, URienstra, MSanders, PScherr, DSchnabel, RSchotten, USohns, CSteinbeck, GSteven, DToennis, TTzeis, Svan Gelder, ICvan Leerdam, RHVernooy, KWadhwa, MWakili, RWillems, SWitt, HZeemering, SKirchhof, PAtrial fibrillationArtificial intelligenceBiomarkersHeart failureAtrial cardiomyopathyCognitive functionDementiaOutcomesQuality of careCostResearchRhythm managementCatheter ablationAnticoagulationBleedingResearch prioritiesTechnologyStrokeIntegrated careScreeningAFNETEHRAGuidelinesConsensus statementAims Recent trial data demonstrate beneficial effects of active rhythm management in patients with atrial fibrillation (AF) and support the concept that a low arrhythmia burden is associated with a low risk of AF-related complications. The aim of this document is to summarize the key outcomes of the 9th AFNET/EHRA Consensus Conference of the Atrial Fibrillation NETwork (AFNET) and the European Heart Rhythm Association (EHRA).Methods and results Eighty-three international experts met in Munster for 2 days in September 2023. Key findings are as follows: (i) Active rhythm management should be part of the default initial treatment for all suitable patients with AF. (ii) Patients with device-detected AF have a low burden of AF and a low risk of stroke. Anticoagulation prevents some strokes and also increases major but non-lethal bleeding. (iii) More research is needed to improve stroke risk prediction in patients with AF, especially in those with a low AF burden. Biomolecules, genetics, and imaging can support this. (iv) The presence of AF should trigger systematic workup and comprehensive treatment of concomitant cardiovascular conditions. (v) Machine learning algorithms have been used to improve detection or likely development of AF. Cooperation between clinicians and data scientists is needed to leverage the potential of data science applications for patients with AF.Conclusions Patients with AF and a low arrhythmia burden have a lower risk of stroke and other cardiovascular events than those with a high arrhythmia burden. Combining active rhythm control, anticoagulation, rate control, and therapy of concomitant cardiovascular conditions can improve the lives of patients with AF. Graphical AbstractOXFORD UNIV PRESS2024info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=17682http://ddd.uab.cat/record/305883EUROPACEISSN: 10995129ISSNe: 15322092reponame:r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pauinstname:Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)Inglésinfo:eu-repo/semantics/openAccessoai:iibsantpau.fundanetsuite.com:p176822026-06-14T12:41:47Z |
| dc.title.none.fl_str_mv |
Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference |
| title |
Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference |
| spellingShingle |
Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference Linz, D Atrial fibrillation Artificial intelligence Biomarkers Heart failure Atrial cardiomyopathy Cognitive function Dementia Outcomes Quality of care Cost Research Rhythm management Catheter ablation Anticoagulation Bleeding Research priorities Technology Stroke Integrated care Screening AFNET EHRA Guidelines Consensus statement |
| title_short |
Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference |
| title_full |
Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference |
| title_fullStr |
Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference |
| title_full_unstemmed |
Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference |
| title_sort |
Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference |
| dc.creator.none.fl_str_mv |
Linz, D Andrade, JG Arbelo, E Boriani, G Breithardt, G Camm, AJ Caso, V Nielsen, JC De Melis, M De Potter, T Dichtl, W Diederichsen, SZ Dobrev, D Doll, N Duncker, D Dworatzek, E Eckardt, L Eisert, C Fabritz, L Farkowski, M Filgueiras-Rama, D Goette, A Guasch, E Hack, G Hatem, S Haeusler, KG Healey, JS Heidbuechel, H Hijazi, Z Hofmeister, LH Hove-Madsen, L Huebner, T Kääb, S Kotecha, D Malaczynska-Rajpold, K Merino, JL Metzner, A Mont, L Ng, GA Oeff, M Parwani, AS Puererfellner, H Ravens, U Rienstra, M Sanders, P Scherr, D Schnabel, R Schotten, U Sohns, C Steinbeck, G Steven, D Toennis, T Tzeis, S van Gelder, IC van Leerdam, RH Vernooy, K Wadhwa, M Wakili, R Willems, S Witt, H Zeemering, S Kirchhof, P |
| author |
Linz, D |
| author_facet |
Linz, D Andrade, JG Arbelo, E Boriani, G Breithardt, G Camm, AJ Caso, V Nielsen, JC De Melis, M De Potter, T Dichtl, W Diederichsen, SZ Dobrev, D Doll, N Duncker, D Dworatzek, E Eckardt, L Eisert, C Fabritz, L Farkowski, M Filgueiras-Rama, D Goette, A Guasch, E Hack, G Hatem, S Haeusler, KG Healey, JS Heidbuechel, H Hijazi, Z Hofmeister, LH Hove-Madsen, L Huebner, T Kääb, S Kotecha, D Malaczynska-Rajpold, K Merino, JL Metzner, A Mont, L Ng, GA Oeff, M Parwani, AS Puererfellner, H Ravens, U Rienstra, M Sanders, P Scherr, D Schnabel, R Schotten, U Sohns, C Steinbeck, G Steven, D Toennis, T Tzeis, S van Gelder, IC van Leerdam, RH Vernooy, K Wadhwa, M Wakili, R Willems, S Witt, H Zeemering, S Kirchhof, P |
| author_role |
author |
| author2 |
Andrade, JG Arbelo, E Boriani, G Breithardt, G Camm, AJ Caso, V Nielsen, JC De Melis, M De Potter, T Dichtl, W Diederichsen, SZ Dobrev, D Doll, N Duncker, D Dworatzek, E Eckardt, L Eisert, C Fabritz, L Farkowski, M Filgueiras-Rama, D Goette, A Guasch, E Hack, G Hatem, S Haeusler, KG Healey, JS Heidbuechel, H Hijazi, Z Hofmeister, LH Hove-Madsen, L Huebner, T Kääb, S Kotecha, D Malaczynska-Rajpold, K Merino, JL Metzner, A Mont, L Ng, GA Oeff, M Parwani, AS Puererfellner, H Ravens, U Rienstra, M Sanders, P Scherr, D Schnabel, R Schotten, U Sohns, C Steinbeck, G Steven, D Toennis, T Tzeis, S van Gelder, IC van Leerdam, RH Vernooy, K Wadhwa, M Wakili, R Willems, S Witt, H Zeemering, S Kirchhof, P |
| author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author |
| dc.subject.none.fl_str_mv |
Atrial fibrillation Artificial intelligence Biomarkers Heart failure Atrial cardiomyopathy Cognitive function Dementia Outcomes Quality of care Cost Research Rhythm management Catheter ablation Anticoagulation Bleeding Research priorities Technology Stroke Integrated care Screening AFNET EHRA Guidelines Consensus statement |
| topic |
Atrial fibrillation Artificial intelligence Biomarkers Heart failure Atrial cardiomyopathy Cognitive function Dementia Outcomes Quality of care Cost Research Rhythm management Catheter ablation Anticoagulation Bleeding Research priorities Technology Stroke Integrated care Screening AFNET EHRA Guidelines Consensus statement |
| description |
Aims Recent trial data demonstrate beneficial effects of active rhythm management in patients with atrial fibrillation (AF) and support the concept that a low arrhythmia burden is associated with a low risk of AF-related complications. The aim of this document is to summarize the key outcomes of the 9th AFNET/EHRA Consensus Conference of the Atrial Fibrillation NETwork (AFNET) and the European Heart Rhythm Association (EHRA).Methods and results Eighty-three international experts met in Munster for 2 days in September 2023. Key findings are as follows: (i) Active rhythm management should be part of the default initial treatment for all suitable patients with AF. (ii) Patients with device-detected AF have a low burden of AF and a low risk of stroke. Anticoagulation prevents some strokes and also increases major but non-lethal bleeding. (iii) More research is needed to improve stroke risk prediction in patients with AF, especially in those with a low AF burden. Biomolecules, genetics, and imaging can support this. (iv) The presence of AF should trigger systematic workup and comprehensive treatment of concomitant cardiovascular conditions. (v) Machine learning algorithms have been used to improve detection or likely development of AF. Cooperation between clinicians and data scientists is needed to leverage the potential of data science applications for patients with AF.Conclusions Patients with AF and a low arrhythmia burden have a lower risk of stroke and other cardiovascular events than those with a high arrhythmia burden. Combining active rhythm control, anticoagulation, rate control, and therapy of concomitant cardiovascular conditions can improve the lives of patients with AF. Graphical Abstract |
| publishDate |
2024 |
| dc.date.none.fl_str_mv |
2024 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=17682 http://ddd.uab.cat/record/305883 |
| url |
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=17682 http://ddd.uab.cat/record/305883 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.publisher.none.fl_str_mv |
OXFORD UNIV PRESS |
| publisher.none.fl_str_mv |
OXFORD UNIV PRESS |
| dc.source.none.fl_str_mv |
EUROPACE ISSN: 10995129 ISSNe: 15322092 reponame:r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau instname:Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau) |
| instname_str |
Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau) |
| reponame_str |
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau |
| collection |
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869413190222217216 |
| score |
15,812429 |